Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
Ciska Verbaanderd, Hannelore Maes, Marco B.E. Schaaf, et al.
ecancermedicalscience (2017) Vol. 11
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

Lysosomal membrane permeabilization and cell death
Fengjuan Wang, Raquel Gómez‐Sintes, Patricia Boya
Traffic (2018) Vol. 19, Iss. 12, pp. 918-931
Open Access | Times Cited: 580
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Francesca Nazio, Matteo Bordi, Valentina Cianfanelli, et al.
Cell Death and Differentiation (2019) Vol. 26, Iss. 4, pp. 690-702
Open Access | Times Cited: 340
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Wojciech Ornatowski, Qing Lü, Manivannan Yegambaram, et al.
Redox Biology (2020) Vol. 36, pp. 101679-101679
Open Access | Times Cited: 302
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review
Domenico Plantone, Tatiana Koudriavtseva
Clinical Drug Investigation (2018) Vol. 38, Iss. 8, pp. 653-671
Open Access | Times Cited: 288
Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer
Simone Patergnani, Alberto Danese, Esmaa Bouhamida, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8323-8323
Open Access | Times Cited: 242
Autophagy in endothelial cells and tumor angiogenesis
Marco B.E. Schaaf, Diede Houbaert, Odeta Meçe, et al.
Cell Death and Differentiation (2019) Vol. 26, Iss. 4, pp. 665-679
Open Access | Times Cited: 181
Targeting autophagy in disease: established and new strategies
Muhammed Koçak, Saba Ezazi Erdi, Guillem Jorba, et al.
Autophagy (2021) Vol. 18, Iss. 3, pp. 473-495
Open Access | Times Cited: 148
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
C. Glenn Begley, Mark Ashton, Jonathan B. Baell, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Closed Access | Times Cited: 113
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
Marta Pérez-Hernández, Alain Arias, David Martínez‐García, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 137
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
Anuradha Kirtonia, Kavita Gala, Stina George Fernandes, et al.
Seminars in Cancer Biology (2020) Vol. 68, pp. 258-278
Closed Access | Times Cited: 135
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Eliise Laura Nirk, Fulvio Reggiori, Mario Mauthe
EMBO Molecular Medicine (2020) Vol. 12, Iss. 8
Open Access | Times Cited: 132
MEK inhibitor resistance mechanisms and recent developments in combination trials
Eucharist Kun, Yvonne T.M. Tsang, Chun Wai Ng, et al.
Cancer Treatment Reviews (2020) Vol. 92, pp. 102137-102137
Open Access | Times Cited: 130
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Francesco Ciccarese, Elisabetta Zulato, Stefano Indraccolo
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 125
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
Satyajit Tripathy, Barsha Dassarma, Somenath Roy, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 2, pp. 106028-106028
Open Access | Times Cited: 112
The unfolded protein response as a target for anticancer therapeutics
Mengxiong Wang, Mary E. Law, Ronald K. Castellano, et al.
Critical Reviews in Oncology/Hematology (2018) Vol. 127, pp. 66-79
Closed Access | Times Cited: 104
Chloroquine against malaria, cancers and viral diseases
Wenmin Zhou, Hui Wang, Yuqi Yang, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 11, pp. 2012-2022
Open Access | Times Cited: 101
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
Umar Mehraj, Rais A. Ganai, Muzafar A. Macha, et al.
Cellular Oncology (2021) Vol. 44, Iss. 6, pp. 1209-1229
Closed Access | Times Cited: 99
The role of photodegradation in the environmental fate of hydroxychloroquine
Dario Dabić, Sandra Babić, Irena Škorić
Chemosphere (2019) Vol. 230, pp. 268-277
Closed Access | Times Cited: 86
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
Cally J. Ho, Sharon M. Gorski
Cancers (2019) Vol. 11, Iss. 11, pp. 1775-1775
Open Access | Times Cited: 83
New drugs are not enough‑drug repositioning in oncology: An update
Romina Armando, Diego Mengual G�mez, Daniel E. Gómez
International Journal of Oncology (2020)
Open Access | Times Cited: 81
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinić, Thomas Efferth, Alfonso T. García‐Sosa, et al.
Drug Resistance Updates (2020) Vol. 52, pp. 100713-100713
Open Access | Times Cited: 80
Drug combination and repurposing for cancer therapy: the example of breast cancer
Ana Salomé Correia, Fátima Gärtner, Nuno Vale
Heliyon (2021) Vol. 7, Iss. 1, pp. e05948-e05948
Open Access | Times Cited: 79
Targeting Autophagy in Breast Cancer
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7836-7836
Open Access | Times Cited: 78
Lysosomes and Cancer Progression: A Malignant Liaison
Eda Machado, Ida Annunziata, Diantha van de Vlekkert, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 76
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling
Chenchu Lin, Alicia M. Blessing, Thomas L. Pulliam, et al.
Oncogene (2021) Vol. 40, Iss. 9, pp. 1690-1705
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top